HIV-1 Targeted Next Generation Sequencing 

The HIV-1 Targeted Next Generation Sequencing (TNGS) assay is the Florida BPHL’s Laboratory Developed Test (LDT) genotype procedure to accompany HIV-1 viral load testing, as needed. The assay is essential in determining if the HIV virus has mutated against specific antiretrovirals and is a barrier to a patient’s SVR status